Haber Pharma Chem: Advancing Healthcare Innovation in Gujarat

Haber Pharma Chem Private Limited is venturing into the realm of Active Pharmaceutical Ingredients (API) with its new unit located in Dhanot, Gandhinagar district, Gujarat. This project marks a significant step forward for the company as it expands its operations into the pharmaceutical sector. With a robust product capacity of 99.6 tonnes per month, the API unit is poised to contribute substantially to the pharmaceutical industry's supply chain, catering to the growing demand for essential pharmaceutical ingredients.

Spanning across a land area of 2.55 acres, the new API unit represents a substantial investment for Haber Pharma Chem Private Limited. With a project cost amounting to ₹7.82 Crore, the company is making a significant financial commitment to establish and operationalize the facility. This investment underscores the company's confidence in the potential of the pharmaceutical sector and its dedication to meeting the evolving needs of the market.

While the available information provides valuable insights into the project's scale and scope, certain details remain undisclosed. Specifically, information regarding the specific APIs manufactured at the unit is crucial for understanding the company's strategic focus and market positioning. Additionally, details about the project's timeline, including its current stage of development and estimated completion date, would provide stakeholders with a clearer understanding of the project's progress and anticipated milestones.

Furthermore, insights into the project's sustainability measures would offer valuable context regarding Haber Pharma Chem Private Limited's commitment to environmental responsibility and resource conservation. Details about water conservation practices, renewable energy initiatives, and other sustainable practices integrated into the project would demonstrate the company's efforts to minimize its environmental footprint and operate responsibly.

News by Rahul Yelligetti